公开(公告)号：GB2004744B

公开(公告)日：1982-05-26

申请号：GB7838177

申请日：1978-09-26

Applicant: SANDERSON A R

IPC: A61K39/385 ,  A61K39/00

公开(公告)号：GB2045256A

公开(公告)日：1980-10-29

申请号：GB8010301

申请日：1980-03-27

Applicant: SANDERSON A R

IPC: A61K39/385 ,  C07G7/00

Abstract: Antigenic materials are combined with MHC antigens through the use of the MHC antigen in the form of a complex with a protein, with which it occurs naturally, for example an HLA-B2M or analogous non-human complex, the antigenic material being attached to the protein of the complex through antibody to that protein.

公开(公告)号：GB2004744A

公开(公告)日：1979-04-11

申请号：GB7838177

申请日：1978-09-26

Applicant: SANDERSON A R

IPC: A61K39/385 ,  A61K39/00

Abstract: An immunologically active preparation for human or veterinary use comprises an antigenic material in combination with an MHC (Major Histocompatibility Complex) antigen, especially Human Lymphocyte Antigen (HLA). The MHC may be papain- solubilized, and the antigenic material may be a bacterial, viral, protozoal or fungal antigen, a toxoid or toxin, a peptide hormone or a hapten. The combination is brought about with a conventional coupling agent.

公开(公告)号：GB2045256B

公开(公告)日：1983-02-09

申请号：GB8010301

申请日：1980-03-27

Applicant: SANDERSON A R

IPC: A61K39/385 ,  C07G7/00